Heart Failure
Conditions
Keywords
central venous pressure, right heart catheterization, hemodynamic congestion
Brief summary
This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).
Interventions
Non-invasive wearable monitor for the assessment of central venous pressure
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosed with NYHA class II-IV heart failure irrespective of ejection fraction * Patient is able to give consent
Exclusion criteria
* Severe tricuspid regurgitation * Mechanical ventilation * Patient is pregnant * Inability to access either of the patient's upper arms.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Agreement with right atrial pressure as measured by Swan Ganz catheter | During the right heart catheterization procedure | Agreement between the CVP/RAP as assessed by the CorWatchTM method and the right arterial pressure (RAP) as measured by SG catheter |
Countries
United States